The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors

Abstract

Nuclear all-trans retinoic acid receptors (RARs) initiate early transcriptional events which engage pluripotent cells to differentiate into specific lineages. RAR-controlled transactivation depends mostly on agonist-induced structural transitions in RAR C-terminus (AF-2), thus bridging coactivators or corepressors to chromatin, hence controlling preinitiation complex assembly. However, the contribution of other domains of RAR to its overall transcriptional activity remains poorly defined. A proteomic characterization of nuclear proteins interacting with RAR regions distinct from the AF-2 revealed unsuspected functional properties of the RAR N-terminus. Indeed, mass spectrometry fingerprinting identified the Bromodomain-containing protein 4 (BRD4) and ALL1-fused gene from chromosome 9 (AF9/MLLT3), known to associate with and regulates the activity of Positive Transcription Elongation Factor b (P-TEFb), as novel RAR coactivators. In addition to promoter sequences, RAR binds to genomic, transcribed regions of retinoid-regulated genes, in association with RNA polymerase II and as a function of P-TEFb activity. Knockdown of either AF9 or BRD4 expression affected differentially the neural differentiation of stem cell-like P19 cells. Clusters of retinoid-regulated genes were selectively dependent on BRD4 and/or AF9 expression, which correlated with RAR association to transcribed regions. Thus RAR establishes physical and functional links with components of the elongation complex, enabling the rapid retinoid-induced induction of genes required for neuronal differentiation. Our data thereby extends the previously known RAR interactome from classical transcriptional modulators to components of the elongation machinery, and unravel a functional role of RAR in transcriptional elongation.

Getting up to speed with transcription elongation by RNA polymerase II

“…The SEC can interact with a subset of co-activators such as Mediator, polymerase-associated factor 1 (PAF1) and Integrator, the latter of which is a complex that interacts with the CTD of Pol II 60,79–82 . Moreover, the SEC can also colocalize with BRD4 at gene promoters 83 . The SEC and BRD4 predominantly mediate the recruitment P-TEFb, but their regulatory importance and composition with regard to paused Pol II release seems to vary across different genes, cell types and stimuli.…”

Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways

“…The release of paused Pol II can be regulated by a number of nuclear receptor (NR)-dependent signaling pathways [65–67] (Table 1). Aiyar et al .…”

Targeting CDK9: a promising therapeutic opportunity in prostate cancer

“…For activation of P-TEFb, BRD4 competes with inhibitory complex HEXIM/7SK and is recruited to transcription start site via histone acetylation. SEC may co-localize with BRD4 at gene promoters and interact with coactivators such as the Mediator and polymerase-associated factor 1 (PAF1) (Flajollet et al 2013). Ultimately, the recruitment of these cofactors depends on TFs that bind to promoters or enhancers.…”